A detailed history of Gunn & CO Investment Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Gunn & CO Investment Management, Inc. holds 835 shares of LLY stock, worth $641,079. This represents 0.51% of its overall portfolio holdings.

Number of Shares
835
Previous 1,534 45.57%
Holding current value
$641,079
Previous $1.39 Million 53196.83%
% of portfolio
0.51%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$772.14 - $960.02 $539,725 - $671,053
-699 Reduced 45.57%
835 $740 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $532,054 - $667,235
734 Added 91.75%
1,534 $1.39 Million
Q1 2024

Apr 26, 2024

SELL
$592.2 - $792.28 $377,823 - $505,474
-638 Reduced 44.37%
800 $622,000
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $419,101 - $494,065
798 Added 124.69%
1,438 $838,000
Q3 2023

Nov 21, 2023

BUY
$434.7 - $599.3 $278,208 - $383,552
640 New
640 $344,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gunn & CO Investment Management, Inc. Portfolio

Follow Gunn & CO Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gunn & CO Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gunn & CO Investment Management, Inc. with notifications on news.